Kristie Ann Wagner

VP, Principal Fin & Acct Off, Entasis Therapeutics.

Companies

Entasis TherapeuticsVP, Principal Fin & Acct Off Feb 25, 2022 to Jul 11, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Entasis Therapeutics0 shares²Jul 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 11, 2022Returned to company 80,500 shares of Entasis Therapeutics²
Feb 24, 2022Granted 10,000 shares of Entasis Therapeutics³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREntasis Therapeutics, VP, Principal Fin & Acct Off
2
SEC EDGAREntasis Therapeutics shares after the filing of Jul 11, 2022
3
SEC EDGARForm 4 filed Feb 25, 2022